Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination antibiotic therapy for infective endocarditis.

Thuan Le1, Arnold S Bayer

  • 1Research and Education Institute at Harbor-University of California, Los Angeles, Torrance, CA 90502, USA. tle@rei.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 21, 2003
PubMed
Summary

Optimizing infective endocarditis (IE) treatment with synergistic antibiotic combinations shows promise, particularly for enterococcal IE. Evidence supports specific combination therapies for certain pathogens, but more data are needed for others like Staphylococcus aureus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human <i>Staphylococcus aureus</i> Bacteremia.

Antibiotics (Basel, Switzerland)·2026
Same author

A pilot study of a digital weight loss program for people with obesity in four diverse cohorts.

Journal of behavioral medicine·2026
Same author

A person-centered approach to digital health technologies for cancer prevention: Qualitative findings on use of technology-based interventions in Houston, Texas.

Preventive medicine reports·2025
Same author

Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.

Antimicrobial agents and chemotherapy·2025
Same author

NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA).

The Journal of antimicrobial chemotherapy·2024
Same author

Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pharmacology

Background:

  • Infective endocarditis (IE) remains a serious condition with high morbidity and mortality, despite advances in medical and surgical care.
  • Optimizing antimicrobial therapy through synergistic antibiotic combinations is a key strategy for improving IE treatment outcomes.
  • Current evidence for proven synergistic approaches in IE is limited across various etiologic pathogens.

Purpose of the Study:

  • To review evidence-based recommendations for combination antimicrobial therapy in infective endocarditis.
  • To focus on IE caused by the most common etiologic pathogens.
  • To evaluate the efficacy of novel and established synergistic antibiotic approaches.

Main Methods:

  • Systematic review of in vitro models, experimental IE models, and human clinical trials.

Related Experiment Videos

  • Analysis of data on combination antimicrobial therapy for common IE pathogens.
  • Evaluation of novel approaches like short-course aminoglycoside therapy and double-beta-lactam combinations.

    • Main Results:

    • Synergistic combination therapy is well-demonstrated for enterococcal IE, with promising novel approaches like short-course aminoglycosides and double-beta-lactams.
    • Short-course combination therapy with cell-wall active agents (CWAs) and aminoglycosides is effective for viridans group streptococci IE.
    • Clinical data supporting the benefit of CWA-aminoglycoside combinations for Staphylococcus aureus IE are limited, despite common clinical use.

    Conclusions:

    • Combination antimicrobial therapy is crucial for optimizing infective endocarditis treatment, with varying levels of evidence for different pathogens.
    • Enterococcal and viridans group streptococci IE have demonstrated effective synergistic treatment strategies.
    • Further clinical trials are needed to confirm the benefits of specific combination therapies, especially for Staphylococcus aureus IE.